CardioRenal Systems, Inc. has developed the only clinically validated solution to the biggest problem today in cardiac surgery and the ICU – Acute Kidney Injury. 

The technology was granted Breakthrough Designation by the FDA and is CE approved with growing adoption across Europe and the Middle East.

The technology was granted Breakthrough Designation by the FDA and is CE approved with growing adoption across Europe and the Middle East.

Biotechnology

Health Care

Health Diagnostics

Medical Devices

CardioRenal Systems Inc. (RenalGuard)

CardioRenal Systems Inc. (RenalGuard)'s headquarters in Milford, United States

Description

People (2)

Ilya Budik

Mark Tauscher

Jobs